Comparison of Treatment Outcomes for Blepharoptosis of Various Etiologies Using a Feedback-enabled Magnetic Device

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

To develop a feedback-enabled magnetic device for management of blepharoptosis and evaluate its efficacy and safety, including the gain of palpebral fissure height, visual field obstruction, blurred vision, foreign body sensation over the cornea, burning or hot sensation over facial skin, and erythema or pruritus over the eyelid, by performing a human trial on patients with blepharoptosis.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: f
View:

• Patients with ptosis; they are capable of understanding and complying with protocol requirements

• Aged 18 years old or older

Locations
Other Locations
Taiwan
E-Da Hospital
RECRUITING
Kaohsiung City
Shin Kong Wu Ho-Su Memorial Hospital
RECRUITING
Taipei
Contact Information
Primary
Ching-Feng Lien, MD, PhD
lien980206@yahoo.com.tw
886-975106033
Time Frame
Start Date: 2023-04-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 40
Treatments
Experimental: Determine device feasibility
by evaluating efficacy and safety of the device. Test the device (duration: 120 mins/each time). Intervention: using the feedback-enabled magnetic device.
Related Therapeutic Areas
Sponsors
Collaborators: National Yang Ming Chiao Tung University, Shin Kong Wu Ho-Su Memorial Hospital, The Industrial Technology Research Institute, National Science and Technology Council, Taiwan
Leads: E-DA Hospital

This content was sourced from clinicaltrials.gov